Latest News

Biologic therapies linked to high remission rates over 2-year follow-up

Researchers identify microbial shifts tied to corneal disease history

Deeper anterior chamber depth and shorter disease course predicted better surgical outcomes

The US FDA approves Lumvoa for TED in active or chronic stages, showing rapid proptosis and diplopia improvements; safety monitoring includes hearing, hyperglycemia and infusion reactions.

Real-world data show dexamethasone intravitreal implant improves vision and thickness in RVO macular edema, with earlier anti-VEGF switching yielding better gains.

Charlie Zhang, MD, reflects on the rising incidence, diagnostic challenges and multidisciplinary management of immune checkpoint inhibitor–associated uveitis

Researchers assessed accommodative changes after foldable iris-fixated phakic IOL implantation for myopic astigmatism

AI models predicting retinal function from OCT could transform geographic atrophy assessment in clinical care and trials

Two cases highlight the diagnostic challenges of Demodex blepharitis and underscore the unmet need for approved targeted therapies in the United Kingdom.

A scoping review finds limited evidence on transition programmes for adolescents moving from paediatric to adult ophthalmology care

A sutureless amniotic membrane matrix achieved faster healing and lower costs than standard PED care in a two-centre NHS audit.

A retrospective study of 114 oculoplastic surgery patients found trehalose added to sodium hyaluronate improved tear break-up time, corneal staining, and meibomian gland loss compared with sodium hyaluronate alone, particularly after eyelid reconstruction.

The CE-marked lens is being placed by selected surgeons across 6 European countries under a company-described early-access program